Form 8-K - Current report:
SEC Accession No. 0001193125-23-007316
Filing Date
2023-01-13
Accepted
2023-01-12 17:37:05
Documents
12
Period of Report
2023-01-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d208959d8k.htm   iXBRL 8-K 20280
  Complete submission text file 0001193125-23-007316.txt   125569

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tcnnf-20230110.xsd EX-101.SCH 2502
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcnnf-20230110_lab.xml EX-101.LAB 15170
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcnnf-20230110_pre.xml EX-101.PRE 9513
6 EXTRACTED XBRL INSTANCE DOCUMENT d208959d8k_htm.xml XML 2993
Mailing Address 6749 BEN BOSTIC ROAD QUINCY FL 32351
Business Address 6749 BEN BOSTIC ROAD QUINCY FL 32351 8505080261
Trulieve Cannabis Corp. (Filer) CIK: 0001754195 (see all company filings)

EIN.: 581882476 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56248 | Film No.: 23526725
SIC: 2833 Medicinal Chemicals & Botanical Products